Buy & Sell CureVac BV (CVAC) – CureVac BV Price Today
Key Stats
- $1.05BMarket Cap
- HealthSector
- -3M Drawdown
- $599.28MEnterprise Value
- -Dividend Yield
- 26 daysTypical Hold Time
CureVac BV (CVAC) is currently valued at a market capitalization of $1.05B, with an enterprise value of $599.28M. Over the past 52 weeks, CureVac BV has traded between a low of $2.59 and a high of $5.6, highlighting its annual price range. On average, investors hold CureVac BV for approximately 26 days, indicating typical investor behavior on the platform.
About CureVac BV
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
Most Recent News
OpenAI plans major upgrade to boost ChatGPT amid IPO and competition with Anthropic.
OpenAI is preparing its biggest upgrade yet, transforming ChatGPT into a superapp with multiple tools like coding and AI agents to better compete with Anthropic. This move aims to attract more corporate clients and increase revenue as OpenAI readies ...
Investors may claim losses after ADMA Biologics shares fell 16.6% amid fraud allegations.
Rosen Law Firm is investigating securities claims against ADMA Biologics following allegations that the company misled investors by inflating revenue through channel stuffing. The stock dropped 16.6% on March 24, 2026, after a short seller report by ...
Anthropic co-founder warns AI industry lacks a 'brake pedal' amid rapid growth and IPO plans.
Anthropic, an AI company backed by Amazon and Google, is preparing for a major IPO potentially valuing it near $1 trillion. Co-founder Jack Clark cautions that the AI industry currently has no mechanism to slow development, likening it to having a ga...